COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Previous |  Page 1955: Articles 19541-19550  | Next

HLA-C* 04:01 is a Genetic Risk Allele for Severe Course of COVID-19
Weiner, J., Suwalski, P., Holtgrewe, M., Thibeault, C., Mueller, M., Patriki, D., Quedenau, C., Krueger, U., Helbig, E. T., Lippert, L., Stubbemann, P., Real, L. M., Sanchez, J. M., Pineda, J. A., Fernandez-Fuertes, M., Wang, X., Karadeniz, Z., Saccomanno, J., Doehn, J.-M., Hubner, R.-H., Hinzmann, B., Salvo, M., Blueher, A., Siemann, S., Jurisic, S., Beer, H., Rutishauser, J., Wiggli, B. J., Schmid, H. R., Danninger, K., Binder, R., Corman, V. M., Muehlemann, B., Braun, A., Ripke, S., Jones, T. C., Suttorp, N., Witzenrath, M., Hippenstiel, S., Zemojtel, T., Skurk, C., Poller, W., Borodina, T., Pa-COVID Study Group, , Sander, L. E., Beule, D., Landmesser, U., Guettouche, T., Kurth, F., Heidecker, B.
10.1101/2020.12.21.20248121 — Posted: 2020-12-24 Discussion: Onsite
"There's No Place Like Home for The Holidays:" Travel and SARS-CoV-2 Test Positivity Following Thanksgiving Weekend
Mehta, S. H., Clipman, S. J., Wesolowski, A., Solomon, S.
10.1101/2020.12.22.20248719 — Posted: 2020-12-24
On an optimal testing strategy for workplace settings operating during the COVID-19 pandemic
Hernandez, X., Valentinotti, S.
10.1101/2020.12.22.20248752 — Posted: 2020-12-24
On the main factors influencing COVID-19 spread and deaths in Mexico: A comparison between Phase I and II
Benita, F., Gasca-Sanchez, F.
10.1101/2020.12.22.20248716 — Posted: 2020-12-24
Forecasting intensive care unit demand during the COVID-19 pandemic: A spatial age-structured microsimulation model
Kluesener, S., Schneider, R., Rosenbaum-Feldbruegge, M., Dudel, C., Loichinger, E., Sander, N., Backhaus, A., Del Fava, E., Esins, J., Fischer, M., Grabenhenrich, L., Grigoriev, P., Grow, A., Hilton, J., Koller, B., Myrskyla, M., Scalone, F., Wolkewitz, M., Zagheni, E., Resch, M. M.
10.1101/2020.12.23.20248761 — Posted: 2020-12-24
SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
Clipman, S. J., Wesolowski, A., Mehta, S. H., Agarwal, S., Cobey, S. E., Cummings, D. A. T., Gibson, D. G., Labrique, A. B., Kirk, G. D., Solomon, S. S.
10.1101/2020.12.23.20248789 — Posted: 2020-12-24
Unravelling the early warning capability of wastewater surveillance for COVID-19: A temporal study on SARS-CoV-2 RNA detection and need for the escalation
Kumar, M., Joshi, M., Patel, A. K., Joshi, C. G.
10.1101/2020.12.22.20248744 — Posted: 2020-12-24
REAL-TIME MECHANISTIC BAYESIAN FORECASTS OF COVID-19 MORTALITY
Gibson, G. C., Reich, N. G., Sheldon, D.
10.1101/2020.12.22.20248736 — Posted: 2020-12-24
A Systematic Review of the Incubation Period of SARS-CoV-2: The Effects of Age, Biological Sex, and Location on Incubation Period
Daley, C., Fydenkevez, M., Ackerman-Morris, S.
10.1101/2020.12.23.20248790 — Posted: 2020-12-24 Discussion: Offsite
Spotlight on the dark figure: Exhibiting dynamics in the case detection ratio of COVID-19 infections in Germany
Schneble, M., De Nicola, G., Kauermann, G., Berger, U.
10.1101/2020.12.23.20248763 — Posted: 2020-12-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).